ABSTRACT
Background The genomic mismatch level between donor and recipient is associated with the risk of acute rejection and long-term graft survival. In the present study, we determined the association of genome-level matching with acute rejection in a single-center kidney transplantation cohort.
Methods Altogether, 1025 pairs of deceased donors and kidney transplant recipients transplanted in 2007–2017 were genotyped. The associations between the sums of whole genome missense variant mismatches and missense mismatches in transmembrane, secretory, and kidney-related proteins, with acute rejection were estimated using Cox proportional hazards model. Additionally, we analyzed 40 common deletion-tagging variants using Cox model.
Results The increasing mismatch sum in kidney-related proteins associated with acute rejection with an unadjusted HR of 1.15 (95% CI, 1.01–1.30; P=0.029) when dividing the sum into quartiles. The sums of other mismatches were not associated with acute rejection. In deletion analysis, a mismatch in rs7542235 (NC_000001.11:g.196854483A>G), genotype GG tagging a homozygous deletion at the complement Factor H-related (CFHR) proteins locus, predisposed to acute rejection with adjusted HR of 2.97 (95% CI, 1.46–6.05; P=0.003).
Conclusions The present study supports that mismatches in gene deletions and kidney-related proteins are novel histocompatibility factors in kidney transplantation. The relative importance of different gene deletions varies between populations, as we found evidence for CFH-related gene deletion but not for the previously reported LIMS1 deletion.
SIGNIFICANCE STATEMENT The first genome-wide association studies have not identified strong candidate genes for complication risks of kidney transplantation whereas matching of non-HLA genes may be promising. The current study determined the association of genome-level matching with acute rejection among 1025 kidney transplant pairs. The increasing mismatch sum in kidney-related proteins was associated with acute allograft rejection. Also, an association between acute allograft rejection and rs7542235 genotype GG, tagging a homozygous deletion at the complement factor H-related (CFHR) loci on chr 1 was found. The present study suggests that mismatches in gene deletions and kidney-related proteins are important novel histocompatibility factors in kidney transplantation.
Competing Interest Statement
I.H. reports receiving research funding from MSD and has ongoing consultancy agreements with Novartis and Hansa Biopharma.
Funding Statement
The study was partially supported by funding from the Government of Finland VTR funding, Munuaissaatio (to SM), Suomen Transplantaatiokirurginen yhdistys ry (to SM), and Academy of Finland (to JP).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study conforms to the principles of the Declaration of Helsinki and has been approved by the ethics committee of Helsinki University Hospital (HUS/1873/2018) and the Finnish National Supervisory Authority for Welfare and Health (V/9161/2019).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The code for variant selection and statistical testing is publicly available in GitHub (https://github.com/FRCBS/Kidney_genome_wide_mismatch). Genetic data are not publicly available due to restrictions issued by the ethical committee and current legislation in Finland that do not allow the distribution of pseudonymized personal data, including genetic and clinical data.
ABBREVIATIONS
- aHUS
- atypical hemolytic uremic syndrome
- CFH
- complement Factor H
- CFHR
- complement Factor H-related protein
- CFHR1
- complement Factor H-related protein 1
- CFHR3
- complement Factor H-related protein 3
- CFHR4
- complement Factor H-related protein 4
- CI
- confidence interval
- ELISA
- enzyme-linked immunosorbent array
- FIMM
- Finnish Institute for Molecular Medicine
- GWAS
- genome-wide association study
- HLA
- human leukocyte antigen
- HR
- hazard ratio
- HSCT
- hematopoietic stem cell transplantation
- IgA
- Immunoglobulin A
- IgG
- Immunoglobulin G
- IQR
- interquartile range
- MHC
- major histocompatibility complex
- MM
- mismatch
- OR
- odds ratio
- PRA
- panel-reactive antibody
- SNP
- single nucleotide polymorphism
- TX
- transplantation
- VEP
- variant effect predictor
- WGS
- whole genome sequencing
